Plenty of evidence have shown that PD-L1 (encoded by CD274) serves critical roles during tumor immune escape as well as tumor invasion and progression, and was proved to be valuable biomarker to predict worse prognosis for human cancers (Qian et al., 2018; Ren et al., 2020; Yi et al., 2021). This evidence concerns the gene CD274 and cancer.